April 2024 in “BENTHAM SCIENCE PUBLISHERS eBooks” The document's conclusion cannot be provided because the document is not readable or understandable.
July 1999 in “Hair transplant forum international” The document could not be read or understood.
February 2025 in “BioNanoScience” January 2026 in “Advances in Clinical Medicine”
January 2005 in “Hair transplant forum international” The document's conclusion cannot be provided because the document is not readable or understandable.
Cepharanthine and tetrandrine show promise as COVID-19 drugs.
June 2017 in “Journal of The American Academy of Dermatology” The new treatment was safe and may effectively treat male pattern hair loss.
November 2025 in “Journal of Investigative Dermatology”
8 citations
,
March 2002 in “Archiv Der Pharmazie” The compound 4c effectively inhibits the enzyme linked to hair loss.